Search - tctmd.com

Displaying 81 - 100 of 124

Sort: Relevancy | Date

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Presentation THT 2026

Renal Replacement Therapies: Overview of Systems and When to Use Each

Presenter: Wendy McCallum

March 03, 2026

Presentation THT 2026

Noninvasive Fluid Removal for ADHF: Turning Eccrine Glands Into Nephrons

Presenter: Daniel R. Bensimhon

March 03, 2026

Presentation THT 2026

Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction

Presenter: Afek Kodesh

March 03, 2026

Presentation THT 2026

Early Cardiac Contractility Modulation (CCM) Therapy Use Reduces Heart Failure-Related Hospitalization

Presenter: Daniel Burkhoff

March 03, 2026

Presentation THT 2026

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Presenter: G. Michael Felker

March 03, 2026

Presentation THT 2026

Who is the Ideal Candidate for Device-Based Therapy for ADHF

Presenter: James E. Udelson

March 03, 2026

Presentation THT 2026

Economic Impact of Passive Monitoring in High-Risk Heart Failure: Cost Avoidance Analysis

Presenter: Afnan Tariq

March 03, 2026

Presentation THT 2026

Final Results of the Safety and Feasibility of Renal Venous Afterload Modulation with the Doraya in Acute Decompensated Heart Failure and Persistent Congestion

Presenter: Lucas Zier

March 03, 2026

Presentation THT 2026

Post-Discharge Trajectories of Artificial Intelligence-Enabled Electrocardiogram in Patients with Heart Failure

Presenter: Hak Seung Lee

March 03, 2026

Presentation THT 2026

A Non-Invasive Hemodynamic-Guided Strategy to Prevent Decompensated Heart Failure: STOP-DHF Trial

Presenter: Allan Böhm

March 03, 2026

Presentation THT 2026

Clinical Evaluation Of The Vsling™ Device For Ventricular Repair In Patients With Heart Failure

Presenter: Gregg W. Stone

March 03, 2026

Presentation THT 2026

LVADs to Jumpstart the Process of Myocardial Regeneration

Presenter: Stavros G. Drakos

March 02, 2026

Presentation THT 2026

Ethics, Bias, and Regulation: Are We Ready for AI at the Bedside?

Presenter: Ami B. Bhatt

March 02, 2026

Presentation THT 2026

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Presenter: Sunjay Kaushal

March 02, 2026

Presentation THT 2026

Engineering the Future: Human-AI Interfaces in Heart Failure Devices

Presenter: Ilan Richter

March 02, 2026

Presentation THT 2026

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Presenter: Eugene Jiaxian Wang

March 02, 2026

Presentation THT 2026

AI in the Trenches: Lessons From Clinical Trial Optimization

Presenter: Jonathan Cunningham

March 02, 2026

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Presenter: Tariq Ahmad

March 02, 2026

Advertisement

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Renal Replacement Therapies: Overview of Systems and When to Use Each

Noninvasive Fluid Removal for ADHF: Turning Eccrine Glands Into Nephrons

Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction

Early Cardiac Contractility Modulation (CCM) Therapy Use Reduces Heart Failure-Related Hospitalization

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Who is the Ideal Candidate for Device-Based Therapy for ADHF

Economic Impact of Passive Monitoring in High-Risk Heart Failure: Cost Avoidance Analysis

Final Results of the Safety and Feasibility of Renal Venous Afterload Modulation with the Doraya in Acute Decompensated Heart Failure and Persistent Congestion

Post-Discharge Trajectories of Artificial Intelligence-Enabled Electrocardiogram in Patients with Heart Failure

A Non-Invasive Hemodynamic-Guided Strategy to Prevent Decompensated Heart Failure: STOP-DHF Trial

Clinical Evaluation Of The Vsling™ Device For Ventricular Repair In Patients With Heart Failure

LVADs to Jumpstart the Process of Myocardial Regeneration

Ethics, Bias, and Regulation: Are We Ready for AI at the Bedside?

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Engineering the Future: Human-AI Interfaces in Heart Failure Devices

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

AI in the Trenches: Lessons From Clinical Trial Optimization

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content